Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

<b>Background</b>: The correction of iron deficiency (ID) with ferric carboxymaltose (FCM) is a recommended intervention in heart failure (HF) with reduced ejection fraction. Our aim is to evaluate, in a real-life setting, the clinical significance of ID screening and FCM treatment in ac...

Full description

Bibliographic Details
Main Authors: Federico Capone, Alberto Cipriani, Leonardo Molinari, Marianna Noale, Beatrice Gusella, Fabrizio Lucente, Sandro Savino, Antonella Bertomoro, Alois Saller, Sandro Giannini, Roberto Vettor
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Personalized Medicine
Subjects:
acute decompensated heart failure
iron deficiency
ferric carboxymaltose
real-life experience
Online Access:https://www.mdpi.com/2075-4426/13/8/1250

Internet

https://www.mdpi.com/2075-4426/13/8/1250

Similar Items